Kunimaro Furuta
Ikeda, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Journal for immunotherapy of cancer
Published: March 16, 2026
Simultaneous gastric and colonic metastasis of invasive lobular carcinoma of the breast.
Journal: Clinical journal of gastroenterology
Published: December 02, 2025
The RANK/RANKL axis controls vascular dynamics in the bone marrow.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 03, 2025
Short- and Long-Term Outcomes of Endoscopic Submucosal Dissection for Gastric Lesions in Elderly Patients Aged 80 Years or Older: Focus on Non-Procedure-Related Adverse Events.
Journal: DEN open
Published: October 03, 2025
Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD.
Journal: Hepatology communications
Published: October 02, 2025
Complete Response of Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus and Right Atrium Involvement to Combined Radiotherapy and Immunotherapy: A Case Report.
Journal: Gastro hep advances
Published: January 21, 2025
What we know and need to know about Fontan-associated liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 16, 2024
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliteration.
Journal: BMC gastroenterology
Published: May 21, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 20, 2024
Genome-wide loss-of-function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus-integrated hepatoma cells.
Journal: Cancer science
Published: October 09, 2023
Glycogen synthase kinase 3 activity enhances liver inflammation in MASH.
Journal: JHEP reports : innovation in hepatology
Published: June 06, 2023
Endotheliopathy in the metabolic syndrome: Mechanisms and clinical implications.
Journal: Pharmacology & therapeutics
Published: November 30, 2022
Last Updated: 09/26/2026